Serum Chitotriosidase Activity in Pulmonary Tuberculosis: Response to Treatment and Correlations with Clinical Parameters
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Chitotriosidase is an accepted marker of macrophage activation. In this study, we investigated serum chitotriosidase levels in pulmonary tuberculosis (PTB). Methods: Forth-two patients with PTB and 30 healthy subjects were enrolled in the study. The radiological extent of PTB, radiological sequela after treatment, and the degree of smear positivity were assessed. Chitotriosidase levels were measured by a fluorometric method. Results: The serum chitotriosidase levels of the PTB patients were significantly higher than those of the control subjects (39.73±24.97 vs. 9.63±4.55 nmol/mL/h, P<0.001). After completion of the standard 6-month antituberculous treatment, chitotriosidase levels in PTB patients significantly decreased (10.47±4.54 nmol/mL/h, P<0.001). Chitotriosidase levels correlated significantly with the radiological extent of PTB, degree of smear positivity, and post-treatment radiological sequela score (r=0.439, r=0.449, and r=0.337, respectively). Conclusions: This study demonstrated that serum chitotriosidase levels increase in PTB; therefore, chitotriosidase can be used as a marker of disease activity, severity, and response to treatment.
Abstract
Background: Chitotriosidase is an accepted marker of macrophage activation. In this study, we investigated serum chitotriosidase levels in pulmonary tuberculosis (PTB). Methods: Forth-two patients with PTB and 30 healthy subjects were enrolled in the study. The radiological extent of PTB, radiological sequela after treatment, and the degree of smear positivity were assessed. Chitotriosidase levels were measured by a fluorometric method. Results: The serum chitotriosidase levels of the PTB patients were significantly higher than those of the control subjects (39.73±24.97 vs. 9.63±4.55 nmol/mL/h, P<0.001). After completion of the standard 6-month antituberculous treatment, chitotriosidase levels in PTB patients significantly decreased (10.47±4.54 nmol/mL/h, P<0.001). Chitotriosidase levels correlated significantly with the radiological extent of PTB, degree of smear positivity, and post-treatment radiological sequela score (r=0.439, r=0.449, and r=0.337, respectively). Conclusions: This study demonstrated that serum chitotriosidase levels increase in PTB; therefore, chitotriosidase can be used as a marker of disease activity, severity, and response to treatment.
참고문헌 (27)
- Di Rosa M, "Effect of interferon-γ, interleukin-10, lipopolysaccharide and tumor necrosis factor-α on chitotriosidase synthesis in human macrophages", Clin Chem Lab Med, 43, pp.499~502 (2005)
- Malaguarnera L, "Chitotriosidase: the yin and yang", Cell Mol Life Sci, 63, pp.3018~3029 (2006)
- Hollak CE, "Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease", J Clin Invest, 93, pp.1288~1292 (1994)
- Michelakakis H, "The expanding spectrum of disorders with elevated plasma chitotriosidase activity: an update", J Inherit Metab Dis, 27, pp.705~706 (2004)
- Bargagli E, "Human chitotriosidase: a potential new marker of sarcoidosis severity", Respiration, 76, pp.234~238 (2008)
- Artieda M, "Serum chitotriosidase activity is increased in subjects with atherosclerosis disease", Arterioscler Thromb Vasc Biol, 23, pp.1545~1652 (2003)
- Malaguarnera L, "Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution", Am J Gastroenterol, 101, pp.2060~2069 (2006)
- Altarescu G, "Plasma chitotriosidase activity in patients with beta-thalassemia", Am J Hematol, 71, pp.7~10 (2002)
- Comabella M, "Plasma chitotriosidase activity in multiple sclerosis", Clin Immunol, 131, pp.216~222 (2009)
- Grosso S, "Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis", Scand J Clin Lab Invest, 64, pp.57~62 (2004)
- Bargagli E, "Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis", Respiration, 74, pp.548~552 (2007)
- Bargagli E, "Chitotriosidase activity in patients with interstitial lung diseases", Respir Med, 101, pp.2176~2181 (2007)
- Gray JW, "Childhood tuberculosis and its early diagnosis", Clin Biochem, 37, pp.450~455 (2004)
- Segura RM, "Adenosine deaminase in body fluids: a useful diagnostic tool in tuberculosis", Clin Biochem, 22, pp.141~148 (1989)
- Deniz O, "Serum total cholesterol, HDL-C and LDL-C concentrations significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis", Clin Biochem, 40, pp.162~166 (2007)
- Bouzas L, "Chitotriosidase activity in pleural effusions", Clin Lab, 53, pp.449~452 (2007)
- Seaton A, "Crofton and Douglas’s Respiratory Diseases. 4th ed" (1989), Blackwell Science
- Deniz O, "Serum total cholesterol, HDL-C and LDL-C concentrations significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis", Clin Biochem, 40, pp.162~166 (2007)
- Poggi A, "Gammadelta T lymphocytes producing IFNgamma and IL-17 in response to Candida albicans or mycobacterial antigens: possible implications for acute and chronic inflammation", Curr Med Chem, 16, pp.4743~4749 (2009)
- van Eijk M, "Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity", Int Immunol, 17, pp.1505~1512 (2005)
- Labadaridis I, "Chitotriosidase in neonates with fungal and bacterial infections", Arch Dis Child Fetal Neonatal, 90, pp.531~532 (2005)
- Lehrnbecher T, "Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia", Leukemia, 19, pp.1745~1750 (2005)
- Choi EH, "Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India", Genes Immun, 2, pp.248~253 (2001)
- Malaguarnera L, "Interferon-gamma, tumor necrosis factor-alpha, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages", J Clin Lab Anal, 19, pp.128~132 (2005)
- Kurt YG, "Serum chitotriosidase enzyme activity in patients with Crimean-Congo hemorrhagic fever", Clin Chem Lab Med, 47, pp.1543~1547 (2009)
- Iyer A, "Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy", Clin Immunol, 131, pp.501~509 (2009)
- Tercelj M, "Chitotriosidase activity in sarcoidosis and some other pulmonary diseases", Scand J Clin Lab Invest, 69, pp.575~578 (2009)